Imperative Care · 13 hours ago
Software Engineer Intern, Robotics
Imperative Care is developing novel robotic-assisted technologies to improve outcomes for ischemic stroke. The Software Engineering Intern will assist in the development of a playback tool for analysis of case telemetry, including implementing visualizations of robotic motion and processing robot sensor information.
Health CareMedicalMedical Device
Responsibilities
Implement visualizations of robotic motion within a workspace using telemetry, configurations, and kinematics
Process and display robot sensor and state machine information
Develop the software infrastructure to efficiently generate analysis metrics of the case progression
Qualification
Required
Experience with Python and C++
Strong understanding of linear algebra
Strong organizational skills: management of priorities, documentation, and timing
Good interpersonal skills, effective communication, and partnership with other departments
Preferred
Knowledge in kinematics, ROS, visualization tools, or software architecture is a plus
Benefits
Valuable hands-on experience with state-of-the-art equipment, instruments, and facilities
Foundational experience and exposure to a variety of roles and areas of focus
Ongoing networking
Learning and professional development opportunities
Mentorship from executive leadership
Social activities
Peer-to-peer interaction
Company
Imperative Care
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
H1B Sponsorship
Imperative Care has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (3)
2023 (5)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$558.97MKey Investors
Ally Bridge GroupD1 Capital Partners
2024-07-25Series E· $150M
2021-07-15Series D· $260M
2021-01-01Debt Financing· $40M
Recent News
BioWorld Financial Watch
2025-09-24
Company data provided by crunchbase